Invention Grant
- Patent Title: Use of pharmaceutical compositions containing mesembrenone
- Patent Title (中): 使用含有美沙昔酮的药物组合物
-
Application No.: US13256686Application Date: 2010-03-16
-
Publication No.: US08552051B2Publication Date: 2013-10-08
- Inventor: Alan Harvey , Nigel Gericke , Alvaro Viljoen
- Applicant: Alan Harvey , Nigel Gericke , Alvaro Viljoen
- Applicant Address: ZA
- Assignee: H. L. Hall & Sons Limited
- Current Assignee: H. L. Hall & Sons Limited
- Current Assignee Address: ZA
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: ZA2009/02003 20090320
- International Application: PCT/IB2010/051132 WO 20100316
- International Announcement: WO2010/106494 WO 20100923
- Main IPC: A61K31/403
- IPC: A61K31/403

Abstract:
The use of mesembrenone and medicaments and dietary supplements containing mesembrenone. The applicant has surprisingly found that mesembrenone exhibits potent PDE-4 inhibition properties and, in addition to being useful in treating conditions that respond to treatment with a PDE-4 inhibitor, has dual activity on account of its serotonin-uptake inhibition properties. Mesembrenone is extracted and isolated, for example as a pure compound, from plant material of the plant family Mesembryanthemaceae. Preferably a plant or plants from the genus Sceletium, more preferably, Sceletium tortuosum(L) N.E.Br is used.
Public/Granted literature
- US20120041045A1 USE OF PHARMACEUTICAL COMPOSITIONS CONTAINING MESEMBRENONE Public/Granted day:2012-02-16
Information query